ProCure Proton Therapy Center welcomes Timothy H. Chen, MD, to a growing list of tri-state physicians with expertise in treating cancer patients with proton therapy.

ProCure Proton Therapy Center welcomes Timothy H. Chen, MD, to a growing list of tri-state physicians with expertise in treating cancer patients with proton therapy. 


April 28, 2023 — ProCure Proton Therapy Center welcomes Timothy H. Chen, MD, to a growing list of tri-state physicians with expertise in treating cancer patients with proton therapy. 

Dr. Chen is a board-certified radiation oncologist and Medical Director of the Central Nervous System (CNS) program at Jersey Shore University Medical Center, where he recently joined the staff. He is also the Director of Proton Therapy in the Department of Radiation Oncology at Hackensack Meridian Health, which will enable him to play a lead role in ProCure’s affiliation with Hackensack Meridian Health. ProCure entered into an affiliation with Hackensack in 2020. 

Additionally, Dr. Chen earned his medical degree from Santiago University of Technology and completed his residency in radiation oncology at New York Presbyterian Hospital - Cornell University, earning two terms as chief resident. He attended the Master of Health Care Management program at Harvard University and is fluent in Mandarin and Taiwanese. Throughout his career, Dr. Chen has delivered numerous presentations, conducted research, and contributed publications to medical literature. 

“ProCure is dedicated to increasing access to proton therapy for residents throughout New Jersey and the tri-state area,” ProCure President Tom Wang said. “Partnering with Hackensack Meridian Health and adding a physician of Dr. Chen’s credentials will help us serve more patients and potentially save more lives with this non-invasive, highly accurate treatment for cancer.” 

Unlike conventional radiation therapy, proton therapy delivers particles to the body that release most of their energy upon impact with the tumor, so there is no “exit” dose. As a result, proton therapy reduces radiation exposure of healthy tissues by more than 60 percent. Pencil Beam Scanning (PBS) is the most advanced form of proton therapy, which utilizes an ultranarrow proton beam that deposits a radiation dose more precisely within a tumor. ProCure is the first center in New Jersey to offer PBS. 

For more information: www.procure.com


Related Content

News | ASTRO

Sept. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has named Siemens Healthineers the inaugural ...

Time September 29, 2026
arrow
News | Proton Therapy

Sept. 28, 2026 — Penn Medicine and Ion Beam Applications (IBA) have formed Noventra Oncology Alliance, a new joint ...

Time September 28, 2026
arrow
News | ASTRO

Sept. 22, 2026 — Leading experts in radiation therapy from the Abramson Cancer Center (ACC) of the University of ...

Time September 24, 2026
arrow
News | ASTRO

Sept.16, 2026 — For appropriately selected patients with muscle-invasive bladder cancer, preserving the bladder can be a ...

Time September 17, 2026
arrow
News | Information Technology

Sept. 16, 2026 — ETHERFAX, a provider of secure document exchange and cloud faxing, has expanded its solution suite with ...

Time September 16, 2026
arrow
News | Radiology Imaging

Sept. 1, 2026 — Leo Cancer Care and GE HealthCare have announced that the two companies intend to work together on GE ...

Time September 11, 2026
arrow
News | ASTRO

Sept. 9, 2026 — The 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, will take place Sept. 26 to 30 ...

Time September 11, 2026
arrow
News | Radiology Imaging

Sept. 1, 2026— A new study from the Harvey L. Neiman Health Policy Institute found that the odds of imaging following an ...

Time September 01, 2026
arrow
News | Teleradiology

Aug. 25, 2026 — Radiology Partners has entered into a definitive agreement to acquire Everlight Radiology, an ...

Time August 26, 2026
arrow
News | Computed Tomography (CT)

Aug. 13, 2026 — Aidoc has announced that the Centers for Medicare & Medicaid Services (CMS) has approved a New ...

Time August 18, 2026
arrow
Subscribe Now